Unique Ligand Binding Sites on CXCR4 Probed by a Chemical Biology Approach: Implications for the Design of Selective Human Immunodeficiency Virus Type 1 Inhibitors
Won‐Tak Choi(University of Illinois Urbana-Champaign), Ziwei Huang(Nanjing University of Chinese Medicine), Navid Madani(Harvard University), Joseph Sodroski(Harvard University), Dongxiang Liu(Thomas Jefferson University), Santosh Kumar, Shaomin Tian, Jing An(SUNY Upstate Medical University), Chang‐Zhi Dong(University of Illinois Urbana-Champaign)
Cited by 71
Related Papers
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
|Molecular Cancer Therapeutics|2006|186
Structural and Functional Characterization of Human CXCR4 as a Chemokine Receptor and HIV-1 Co-receptor by Mutagenesis and Molecular Modeling Studies
|Journal of Biological Chemistry|2001|138
Bio-template synthesis of Mo-doped polymer carbon nitride for photocatalytic hydrogen evolution
|Applied Catalysis B: Environmental|2019|133
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
|Frontiers in Oncology|2021|125
Exploring the Stereochemistry of CXCR4-Peptide Recognition and Inhibiting HIV-1 Entry with d-Peptides Derived from Chemokines
|Journal of Biological Chemistry|2002|117